Literature DB >> 28868252

The Importance of Fertility Preservation Counseling in Patients with Gynecologic Cancer.

Salvatore Giovanni Vitale1, Valentina Lucia La Rosa2, Agnese Maria Chiara Rapisarda3, Antonio Simone Laganà1.   

Abstract

Entities:  

Year:  2017        PMID: 28868252      PMCID: PMC5565906     

Source DB:  PubMed          Journal:  J Reprod Infertil        ISSN: 2228-5482


× No keyword cloud information.
It is estimated that gynecologic cancer has an incidence of 17% in the world (1). The most common gynecologic cancer is endometrial cancer with an incidence of 53% (2, 3). Although in most cases endometrial cancer manifests during menopause, in 25% of cases it can affect women in premenopausal age and in 2% of cases under the age of 40 (2). The treatment of this type of gynecological cancer is usually surgical and includes hysterectomy and bilateral salpingo oophorectomy (4–6). Adjuvant chemotherapy and/or radiotherapy is recommended in cases at high risk of recurrence and in the later stages of cancer (2, 6). Ovarian cancer is the second most common gynecological malignancy and the leading cause of death for gynecologic cancer in Western countries (2). In most cases, it is diagnosed in advanced stages and mainly affects women aged between 55 and 65. The treatment of ovarian cancer usually involves a combination of surgery and chemotherapy (7–9). Cervical cancer is the second cancer in women worldwide. However, in Western countries, thanks to the diffusion of prevention campaigns through systematic screening program for women aged between 25 and 65, the incidence of this cancer has been greatly reduced (10). Cervical cancer is often diagnosed in reproductive age and surgical treatment may be placed alongside radiation therapy (2, 11). Thanks to progress made in the field of gynecologic oncology, the survival rate for women with gynecologic cancer is greatly increased over the years. Consequently, a primary objective in these cases is to gradually improve the quality of life of patients. Indeed, the experience of a gynecological cancer has a very strong impact on the psychological well-being of women; surgical treatment and chemotherapy can impair female identity and also sexual functioning (2, 3, 12–14). Several studies confirm that women with gynecologic cancer experience low levels of quality of life, anxiety and depressive symptoms, suicidal thoughts, feelings of anger and shame, and low self-esteem (1, 3, 12–17). Moreover, when cancer affects women in child-bearing age, treatments can jeopardize reproductive capacity. The possible infertility due to cancer in women can be more devastating than the cancer itself and the possibility to have a child after cancer can be an important incentive in the therapeutic process (18–20). In the light of these general considerations, techniques for fertility preservation in women with gynecologic cancer can be very important for the improvement of quality of life of these patients (19–21). In Italy, according to the Guidelines for the preservation of fertility in cancer patients published in 2003, a conservative therapy for fertility preservation may be proposed in case of good prognosis and only in the presence of close follow-up and in cancer centers with experience and adequate follow-up protocols (22). Several international studies have shown that an adequate counseling about the fertility preservation treatments is associated with an improved quality of life of women who survive from a gynecological cancer (19–22). However, in many cases, there is not adequate information about this type of treatment. The aforementioned Guidelines recommend that reproductive counseling should be offered immediately after the cancer diagnosis in order to come to an agreement with the patient about the best fertility preservation technique which varies depending on the cancer and reproductive prognosis (22). Reproductive counseling requires a multidisciplinary approach since it is necessary not only to choose the most appropriate preservation technique according to the prognosis and the risk of infertility related to cancer treatments, but also to assess the real motivation of woman to face a pregnancy and to become mother (22, 23). Therefore, the presence of the psychologist, along with the oncologist and the specialist in reproductive medicine, is important to convey correct information to patients with gynecological cancer who wish to preserve their procreative capacity (24, 25). In conclusion, it is appropriate to conduct further research about this topic in order to minimize the impact of cancer treatments on quality of life and psychological well-being of women with gynecological cancer.
  24 in total

Review 1.  The role of cytoreductive surgery in advanced-stage ovarian cancer: a systematic review.

Authors:  Salvatore Giovanni Vitale; Ilaria Marilli; Melissa Lodato; Alessandro Tropea; Antonio Cianci
Journal:  Updates Surg       Date:  2013-05-08

2.  Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer.

Authors:  Joseph M Letourneau; Erin E Ebbel; Patricia P Katz; Audra Katz; Wei Z Ai; A Jo Chien; Michelle E Melisko; Marcelle I Cedars; Mitchell P Rosen
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

Review 3.  Psychological Counseling of Female Fertility Preservation Patients.

Authors:  Angela K Lawson; Susan C Klock; Mary Ellen Pavone; Jennifer Hirshfeld-Cytron; Kristin N Smith; Ralph R Kazer
Journal:  J Psychosoc Oncol       Date:  2015

4.  Decision-making in female fertility preservation is balancing the expected burden of fertility preservation treatment and the wish to conceive.

Authors:  Ö Baysal; L Bastings; C C M Beerendonk; S A E Postma; J IntHout; C M Verhaak; D D M Braat; W L D M Nelen
Journal:  Hum Reprod       Date:  2015-06-01       Impact factor: 6.918

5.  Efficacy of IVF following conservative management of endometrial cancer.

Authors:  Diego Rossetti; Giorgio Bogani; Marco Carnelli; Salvatore Giovanni Vitale; Giuseppe Grosso; Luigi Frigerio
Journal:  Gynecol Endocrinol       Date:  2014-02-25       Impact factor: 2.260

6.  Treatment outcomes and quality-of-life assessment in a university-based fertility preservation program: results of a registry of female cancer patients at 2 years.

Authors:  Andrea E Reh; Lucy Lu; Rachel Weinerman; James Grifo; Lewis Krey; Nicole Noyes
Journal:  J Assist Reprod Genet       Date:  2011-03-22       Impact factor: 3.412

7.  Quality of life and sexual functioning in endometrial cancer survivors.

Authors:  Meike Becker; Tetyana Malafy; Michaela Bossart; Karl Henne; Gerald Gitsch; Dominik Denschlag
Journal:  Gynecol Oncol       Date:  2010-12-14       Impact factor: 5.482

Review 8.  Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.

Authors:  Fani Kokka; Andrew Bryant; Elly Brockbank; Melanie Powell; David Oram
Journal:  Cochrane Database Syst Rev       Date:  2015-04-07

Review 9.  The physical consequences of gynecologic cancer surgery and their impact on sexual, emotional, and quality of life issues.

Authors:  Jeanne Carter; Cara Stabile; Abigail Gunn; Yukio Sonoda
Journal:  J Sex Med       Date:  2013-02       Impact factor: 3.802

10.  Deciding about fertility preservation after specialist counselling.

Authors:  L Bastings; Ö Baysal; C C M Beerendonk; J IntHout; M A F Traas; C M Verhaak; D D M Braat; W L D M Nelen
Journal:  Hum Reprod       Date:  2014-06-10       Impact factor: 6.918

View more
  12 in total

1.  Uterine manipulator in total laparoscopic hysterectomy: safety and usefulness.

Authors:  Yara Abdel Khalek; Roger Bitar; Costas Christoforou; Simone Garzon; Alessandro Tropea; Antonio Biondi; Zaki Sleiman
Journal:  Updates Surg       Date:  2019-10-12

2.  Net survival of patients with colorectal cancer: a comparison of two periods.

Authors:  Zdravko Štor; Rok Blagus; Alessandro Tropea; Antonio Biondi
Journal:  Updates Surg       Date:  2019-06-12

3.  RARE MALIGNANT FEMALE ADNEXAL TUMOR OF WOLFFIAN ORIGIN (FATWO) WITH MULTIPLE RELAPSES AND CHEMOTHERAPY REGIMENS.

Authors:  A Piciu; C Cainap; D Sur; A Havasi; B Fetica; O Balacescu; A Mester; S Cainap
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

4.  A protocol to isolate and qualify purified human preantral follicles in cases of acute leukemia, for future clinical applications.

Authors:  Elodie Mouloungui; Tristan Zver; Christophe Roux; Clotilde Amiot
Journal:  J Ovarian Res       Date:  2018-01-05       Impact factor: 4.234

Review 5.  Fertility preservation in gynaecologic cancers.

Authors:  Francesca De Felice; Claudia Marchetti; Anna Di Pinto; Angela Musella; Innocenza Palaia; Maria Grazia Porpora; Ludovico Muzii; Vincenzo Tombolini; Pierluigi Benedetti Panici; Federica Tomao
Journal:  Ecancermedicalscience       Date:  2018-01-16

6.  Central Pathology Review in SENTIX, A Prospective Observational International Study on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (ENGOT-CX2).

Authors:  Kristyna Nemejcova; Roman Kocian; Christhardt Kohler; Jiri Jarkovsky; Jaroslav Klat; Alberto Berjon; Radovan Pilka; Borek Sehnal; Blanca Gil-Ibanez; Ezequiel Lupo; Almerinda Petiz; Octavio Arencibia Sanchez; Peter Kascak; Fabio Martinelli; Alessandro Buda; Jiri Presl; Marc Barahona; Luc van Lonkhuijzen; Wiktor Szatkowski; Lubos Minar; Maja Pakiz; Pavel Havelka; Cristina Zorrero; Marcin Misiek; Leon Cornelius Snyman; Dariusz Wydra; Ignace Vergote; Alla Vinnytska; Mikulas Redecha; Martin Michal; Solveig Tingulstad; Barbara Kipp; Grzegorz Szewczyk; Robert Toth; Francisco Javier de Santiago Garcia; Pluvio Jesus Coronado Martin; Robert Poka; Karl Tamussino; Mathieu Luyckx; Maxime Fastrez; Juan Carlos Staringer; Anna Germanova; Andrea Plaikner; Sylva Bajsova; Pavel Dundr; Nina Mallmann-Gottschalk; David Cibula
Journal:  Cancers (Basel)       Date:  2020-04-29       Impact factor: 6.639

7.  A preliminary cervical cancer screening cascade for eight provinces rural Chinese women: a descriptive analysis of cervical cancer screening cases in a 3-stage framework.

Authors:  Shu-Xia Wang; Jiu-Ling Wu; Rui-Min Zheng; Wei-Yi Xiong; Jing-Yi Chen; Lan Ma; Xiao-Min Luo
Journal:  Chin Med J (Engl)       Date:  2019-08-05       Impact factor: 2.628

8.  Choosing the most appropriate minimally invasive approach to treat gynecologic cancers in the context of an enhanced recovery program: Insights from a comprehensive cancer center.

Authors:  Antoine Netter; Camille Jauffret; Clément Brun; Laura Sabiani; Guillaume Blache; Gilles Houvenaeghel; Eric Lambaudie
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

9.  Predictors of Absent High-grade Cervical Intraepithelial Neoplasia (CIN) in Loop Electrosurgical Excision Procedure Specimens of Patients with Colposcopic Directed Biopsy-Confirmed High-Grade CIN

Authors:  Yenrudee Poomtavorn; Chamnan Tanprasertkul; Araya Sammor; Komsun Suwannarurk; Yuthadej Thaweekul
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26

Review 10.  Recent Advancements in Engineered Biomaterials for the Regeneration of Female Reproductive Organs.

Authors:  Yoon Young Kim; Hoon Kim; Sung Woo Kim; Seung-Yup Ku
Journal:  Reprod Sci       Date:  2021-04-01       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.